drugset / Trial / NCT00290979
Efficacy and Safety of Insulin Glulisine in Type 1 Diabetes Mellitus
RandomizedParallel-groupOpen-labelTreatment
Summary
* To evaluate non-inferiority in the efficacy of HMR1964 as compared with Insulin lispro in terms of the change in HbA1C from baseline to endpoint. * To compare the safety of HMR1964 with insulin lispro.
Timeline
- Start
- 2004-12
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Insulin glulisine | Protein / enzyme biologic | — | — |